27 October 2025
Innovative facial analysis app recognises pain in care home residents
Danecroft is a 34-bed care home in Bedford, predominantly caring for people living with dementia but also other conditions such as Parkinson’s and MS. Since…
Home » News » Alzheimer’s disease drug, lecanemab
An NHS spokesperson said:
“The NHS now awaits a final decision from the National Institute for Health and Care Excellence that will look at the clinical benefits and cost-effectiveness of lecanemab and determine if it should be routinely offered by the NHS in England.
“Lecanemab is the first disease modifying treatment for Alzheimer’s disease with a market approval in the UK, and to ensure the health system is prepared for future advances in treatments, a dedicated NHS team is also looking ahead to 27 other drugs which are currently in advanced clinical trials that could be potentially approved by 2030.”
For press enquiries, please email blmkicb.communications@nhs.net
27 October 2025
Innovative facial analysis app recognises pain in care home residents
Danecroft is a 34-bed care home in Bedford, predominantly caring for people living with dementia but also other conditions such as Parkinson’s and MS. Since…
24 October 2025
Half term clinics to offer catch-up vaccinations for children
Parents of children who are behind on any of their immunisations have been reminded that there will be an opportunity to catch up on any…
17 October 2025
Local care providers use digital toolkit to monitor vital signs and prevent…
A remote monitoring toolkit has demonstrated potential for empowering care staff to make data-led healthcare decisions about the people they care for. The Whzan blue box measures vital signs such…
15 October 2025
One in five eligible people has already had their flu jab
One in five people eligible for the flu immunisation in Bedfordshire, Luton and Milton Keynes has already had their vaccination, new figures show. It’s always a good idea to get…
9 October 2025
Robotic pets comfort Bedford care home residents with dementia
Bedford-based care home residents are reaping the benefits of robotic therapy pets. Hepworth House Residential Care Home has 15 residents and since April 2025, two residents with dementia have been…
2 October 2025
Digital tool improves mobility and balance in people at risk of falls
The largest real-world evaluation of GaitSmart, an AI-driven digital tool for people with gait (walking pattern) and mobility issues across four sites in Bedfordshire, Luton and Milton Keynes, has seen improved health…